%
ECM retention for natural joint support
x
faster fluid rebound after stress
prep time. No spinning or blood draw.
solution for joints, ligaments, and soft tissue
For cases that demand more than just temporary relief

Clinical Applications

StrideGuard is intended for use in horses experiencing joint instability, soft tissue degeneration, or post-traumatic recovery. It is most effective in performance and working horses exposed to repetitive impact or inflammation. It can be administered as a stand-alone treatment or integrated into broader care plans.
Simple to deliver, powerful in effect

Administration & Handling

StrideGuard comes pre-packaged and sterile, requiring no spinning, blood draw, or special equipment. It is administered via standard intra-articular injection technique or directly into soft tissue, depending on the condition being treated. Because the formulation is consistent from dose to dose, veterinarians can expect predictable handling and response with every application. Its stability and ease of use also make it ideal for field-based care, particularly in rural or ambulatory practices where access to lab tools may be limited.
Specification Details
Product Name StrideGuard
Type Regenerative Injectable Matrix
Source Material Equine umbilical cord tissue (Wharton’s Jelly)
Use Intra-articular and soft tissue injection
Sterility Sterile, ready-to-use
Formulation ECM-rich, viscoelastic regenerative fluid
Packaging Single-use vial
Storage Requirements Refrigerated (do not freeze)
Shelf Life 12 months from manufacture date
Administration Administered by licensed veterinary professional
Regenerative function beyond symptom management

Why Choose StrideGuard

Unlike PRP and BMAC therapies, StrideGuard is not dependent on patient-derived samples, which reduces variability and speeds up the treatment process. It also offers greater regenerative potential than hyaluronic acid, which only provides lubrication without contributing to tissue remodeling. StrideGuard combines mechanical protection with biological activity, helping horses recover faster and maintain long-term joint health.
  • Joint lubrication and viscoelasticity
  • Tissue repair and remodeling
  • Reduced post-treatment inflammation
Common Topics Explained

Frequently asked questions

How is StrideGuard different from PRP or BMAC products?
StrideGuard does not require blood or bone marrow collection from the patient. It is a lab-prepared, cord-derived matrix with consistent regenerative components. This eliminates prep time and patient variability.
Can StrideGuard be used in the field?
Yes. It is fully sterile and ready to inject, making it ideal for mobile vets and in-field treatments. No special equipment is needed.
What types of conditions is StrideGuard best suited for?
StrideGuard is effective for joint and soft tissue conditions including navicular syndrome, stifle injuries, suspensory ligament strain, osteochondral defects, and post-operative support. It can also be used preventatively in performance horses.
How quickly does StrideGuard begin working?
Most horses show noticeable improvement in comfort and movement within days. Its viscoelastic properties help restore lubrication quickly, while the ECM content supports longer-term repair and remodeling.
Can it be used alongside other therapies?
Yes. StrideGuard can be integrated into multi-modal treatment plans that may include rest, anti-inflammatories, physical therapy, or other injectables. Always follow your clinic's protocols for combined use.